CTICNASDAQHealthcare · Biotechnology

CTI BioPharma Corp.

$9.10+0.06%(+$0.01)

TickerSpark Score

64/100

Mixed

Valuation

Profitability

Growth

Health

100

Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CTIC research report →

52-Week Range100% of range

Low $4.01

Current $9.10

High $9.10

Companywww.ctibiopharma.com

CTI BioPharma Corp. , a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients with myelofibrosis.

CEO: Adam R. Craig
IPO: 1997
Employees: 127
HQ: Seattle, WA, US

Price Chart

+52.52% · this period

Valuation

Market Cap: $1.20B
P/E: -11.46
P/S: 22.23
P/B: -59.35
EV/EBITDA: -15.27
Div Yield: 0.00%

Profitability

Gross Margin: 93.49%
Op Margin: -147.91%
Net Margin: -168.76%
ROE: 1318.48%
ROIC: -84.24%

Growth & Income

Revenue: $53.95M · 0.00%
Net Income: $-91,041,000 · 8.63%
EPS: $-0.79 · 28.83%
Op Income: $-79,797,000
FCF YoY: -25.10%

Performance & Tape

52W High: $9.10
52W Low: $4.01
50D MA: $7.34
200D MA: $5.86
Beta: 0.83
Avg Volume: 5.66M

Get TickerSpark's AI analysis on CTIC

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Recent Insider Transactions

Date	Insider	Role	Type	Shares	Value
Jun 26, 23	BVF PARTNERS L P/IL	director, 10 percent owner:	other	43,139	$392.56K
Jun 26, 23	BVF PARTNERS L P/IL	director, 10 percent owner:	other	12	$0
Jun 26, 23	BVF PARTNERS L P/IL	director, 10 percent owner:	other	17	$0
Jun 26, 23	BVF PARTNERS L P/IL	director, 10 percent owner:	sell	80,000	$264.00K
Jun 26, 23	BVF PARTNERS L P/IL	director, 10 percent owner:	sell	80,000	$359.20K
Jun 26, 23	BVF PARTNERS L P/IL	director, 10 percent owner:	sell	80,000	$326.40K
Jun 26, 23	BVF PARTNERS L P/IL	director, 10 percent owner:	sell	60,000	$276.60K
Jun 26, 23	BVF PARTNERS L P/IL	director, 10 percent owner:	sell	50,000	$212.50K
Jun 26, 23	BVF PARTNERS L P/IL	director, 10 percent owner:	sell	120,000	$100.93K
Jun 26, 23	PERRY MATTHEW D	director	sell	120,000	$100.93K